ReviewRadiology. Imaging cancer2023
A Review of Theranostics: Perspectives on Emerging Approaches and Clinical Advancements.
Open access · diamondAbstract readReview
In one paragraph
Review in Radiology. Imaging cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers.
0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed
36.5field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
98 citing papers in PubMed, 159 citations in OpenAlex.
- Application of theranostics in thyroid cancer management.The Journal of clinical endocrinology and metabolism · 2026Review
- Tools for providing information to patients about high-tech medical resources for treatment of cancer.Acta oncologica (Stockholm, Sweden) · 2026Review
- The Next Frontier in Quantitative Co-Clinical Imaging to Advance Functional Precision Oncology.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026Article
- Targeted Radionuclide Therapy: Current Landscape and Combination Approaches to Improve Oncology Outcomes.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026Review
- Development of novel GPC2-directed radiotheranostics and CAR T cell therapy for neuroblastoma.Molecular therapy : the journal of the American Society of Gene Therapy · 2026Article
- Diverse DTPA-chelated lanthanides with relevance for nuclear medicine bound to an engineered lipocalin reveal conserved ligand geometry.Acta crystallographica. Section F, Structural biology communications · 2026Article
- The Evolution of FAP-Targeted CAR T-Cell Therapy in Solid Tumors: From Immunotherapy to Immunotheranostic Applications.International journal of molecular sciences · 2026Review
- Chemical Scaffolds Driving Modern Anticancer Drug Discovery and Radiotheranostics: Structural Determinants, Translational Opportunities and Future Perspectives.Pharmaceuticals (Basel, Switzerland) · 2026Review
- Stable core-encapsulation of indium-111 in crosslinked polyionic complex micelles and assessment of its biodistribution.EJNMMI radiopharmacy and chemistry · 2026Article
- Protein-Based Nanomaterials for Cancer Therapy: A Comparative and Translational Perspective.Pharmaceutics · 2026Review
- Synergistic Effect of Linebacker-1 With Radiation Therapy in a Mouse Lung Cancer Model.Advances in radiation oncology · 2026Article
- Review
- Radiopharmaceutical Therapy in Oncology: Perspectives from Transatlantic Experts.Oncology and therapy · 2026Review
- Nanobody-Conjugated Theranostic Prodrug Targeting αAdvanced healthcare materials · 2026Article
- Brain Cancer: Molecular Alterations and Emerging Trends in Neuropharmacology.International journal of molecular sciences · 2026Review
- Article
- Precision theranostics in oncology: integrating antibody-drug conjugates, radioimmunotherapy, and immuno‑PET for adaptive cancer care.Discover oncology · 2026Review
- Focused Ultrasound Ablation for Neurological Disorders.Biological psychiatry · 2026Review
- Pair production tomography enables imaging of MeV-scale gamma-emitting theranostic radionuclides.Research square · 2026Article
- Radiation stability and performance of TEHDGA resin for theranostic scandium radionuclide purification.EJNMMI radiopharmacy and chemistry · 2026Article
38 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 1 institution in 1 country.
Brian J BurkettFrom the Department of Radiology (B.J.B., D.J.B., D.R.J., M.K.P., A.T.P., C.B.H., G.B.J., A.T.K.) and Division of Medical Oncology (P.W.M., A.R.L., T.R.H.), Mayo Clinic, 200 First St SW, Rochester, MN 55905; and Department of Nuclear Medicine, Anadolu Medical Center, Gebze/Kocaeli, Turkey (K.B.).ORCID 0000-0002-0457-5712
David J BartlettFrom the Department of Radiology (B.J.B., D.J.B., D.R.J., M.K.P., A.T.P., C.B.H., G.B.J., A.T.K.) and Division of Medical Oncology (P.W.M., A.R.L., T.R.H.), Mayo Clinic, 200 First St SW, Rochester, MN 55905; and Department of Nuclear Medicine, Anadolu Medical Center, Gebze/Kocaeli, Turkey (K.B.).ORCID 0000-0002-3291-4208
Patrick W McGarrahFrom the Department of Radiology (B.J.B., D.J.B., D.R.J., M.K.P., A.T.P., C.B.H., G.B.J., A.T.K.) and Division of Medical Oncology (P.W.M., A.R.L., T.R.H.), Mayo Clinic, 200 First St SW, Rochester, MN 55905; and Department of Nuclear Medicine, Anadolu Medical Center, Gebze/Kocaeli, Turkey (K.B.).
Akeem R LewisFrom the Department of Radiology (B.J.B., D.J.B., D.R.J., M.K.P., A.T.P., C.B.H., G.B.J., A.T.K.) and Division of Medical Oncology (P.W.M., A.R.L., T.R.H.), Mayo Clinic, 200 First St SW, Rochester, MN 55905; and Department of Nuclear Medicine, Anadolu Medical Center, Gebze/Kocaeli, Turkey (K.B.).ORCID 0000-0002-7347-1861
Derek R JohnsonFrom the Department of Radiology (B.J.B., D.J.B., D.R.J., M.K.P., A.T.P., C.B.H., G.B.J., A.T.K.) and Division of Medical Oncology (P.W.M., A.R.L., T.R.H.), Mayo Clinic, 200 First St SW, Rochester, MN 55905; and Department of Nuclear Medicine, Anadolu Medical Center, Gebze/Kocaeli, Turkey (K.B.).ORCID 0000-0002-4217-5517
Kezban BerberoğluFrom the Department of Radiology (B.J.B., D.J.B., D.R.J., M.K.P., A.T.P., C.B.H., G.B.J., A.T.K.) and Division of Medical Oncology (P.W.M., A.R.L., T.R.H.), Mayo Clinic, 200 First St SW, Rochester, MN 55905; and Department of Nuclear Medicine, Anadolu Medical Center, Gebze/Kocaeli, Turkey (K.B.).
Mukesh K PandeyFrom the Department of Radiology (B.J.B., D.J.B., D.R.J., M.K.P., A.T.P., C.B.H., G.B.J., A.T.K.) and Division of Medical Oncology (P.W.M., A.R.L., T.R.H.), Mayo Clinic, 200 First St SW, Rochester, MN 55905; and Department of Nuclear Medicine, Anadolu Medical Center, Gebze/Kocaeli, Turkey (K.B.).ORCID 0000-0002-2332-5305
Annie T PackardFrom the Department of Radiology (B.J.B., D.J.B., D.R.J., M.K.P., A.T.P., C.B.H., G.B.J., A.T.K.) and Division of Medical Oncology (P.W.M., A.R.L., T.R.H.), Mayo Clinic, 200 First St SW, Rochester, MN 55905; and Department of Nuclear Medicine, Anadolu Medical Center, Gebze/Kocaeli, Turkey (K.B.).
Thorvardur R HalfdanarsonFrom the Department of Radiology (B.J.B., D.J.B., D.R.J., M.K.P., A.T.P., C.B.H., G.B.J., A.T.K.) and Division of Medical Oncology (P.W.M., A.R.L., T.R.H.), Mayo Clinic, 200 First St SW, Rochester, MN 55905; and Department of Nuclear Medicine, Anadolu Medical Center, Gebze/Kocaeli, Turkey (K.B.).ORCID 0000-0001-8460-1257
Carrie B HruskaFrom the Department of Radiology (B.J.B., D.J.B., D.R.J., M.K.P., A.T.P., C.B.H., G.B.J., A.T.K.) and Division of Medical Oncology (P.W.M., A.R.L., T.R.H.), Mayo Clinic, 200 First St SW, Rochester, MN 55905; and Department of Nuclear Medicine, Anadolu Medical Center, Gebze/Kocaeli, Turkey (K.B.).ORCID 0000-0002-6195-5201
Geoffrey B JohnsonFrom the Department of Radiology (B.J.B., D.J.B., D.R.J., M.K.P., A.T.P., C.B.H., G.B.J., A.T.K.) and Division of Medical Oncology (P.W.M., A.R.L., T.R.H.), Mayo Clinic, 200 First St SW, Rochester, MN 55905; and Department of Nuclear Medicine, Anadolu Medical Center, Gebze/Kocaeli, Turkey (K.B.).ORCID 0000-0002-4866-1401
A Tuba KendiFrom the Department of Radiology (B.J.B., D.J.B., D.R.J., M.K.P., A.T.P., C.B.H., G.B.J., A.T.K.) and Division of Medical Oncology (P.W.M., A.R.L., T.R.H.), Mayo Clinic, 200 First St SW, Rochester, MN 55905; and Department of Nuclear Medicine, Anadolu Medical Center, Gebze/Kocaeli, Turkey (K.B.).ORCID 0000-0003-3892-4754
Mayo Clinic · US
Funding
No grant is acknowledged in the PubMed record.
Abstract
Theranostics is the combination of two approaches-diagnostics and therapeutics-applied for decades in cancer imaging using radiopharmaceuticals or paired radiopharmaceuticals to image and selectively treat various cancers. The clinical use of theranostics has increased in recent years, with U.S. Food and Drug Administration (FDA) approval of lutetium 177 (
Indexed as
NeoplasmsPrecision MedicineHumansMalePositron Emission Tomography Computed TomographyRadioisotopesRadiopharmaceuticalsUnited StatesRadioisotopesRadiopharmaceuticalsDosimetryMolecular ImagingMolecular Imaging–CancerMolecular Imaging–Clinical TranslationMolecular Imaging–Target DevelopmentOncologyPET/CTRadiobiologyRadionuclide TherapySPECT/CT
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.